GlassScriptPhysician profile
Thomas T Tarin
NPI 1427081405
$6,249.65
in general payments reported to CMS, 2019-2025
29 companies · $949 in 2025
The $949 reported for 2025 was more than what 78% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $858 · 2020: $1,753 · 2021: $434 · 2022: $947 · 2023: $802 · 2024: $508 · 2025: $949.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,258.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $2,941.49 | 2019-2025 | |
| Stryker Corporation | $615.61 | 2019-2025 | Scopis Ent, Xpress Loprofile, Audion Et Dilation System |
| Smith+Nephew, INC. | $451.56 | 2019-2025 | Tula |
| Optinose US, INC. | $411.43 | 2019-2022 | |
| Acclarent, INC | $323.15 | 2019-2023 | Trudi Nav Cable |
| Glaxosmithkline, LLC. | $309.79 | 2021-2025 | Nucala |
| Genzyme Corporation | $185.78 | 2019-2025 | |
| Spirair, INC. | $141.42 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $119.99 | 2019 | |
| Cequr Corporation | $103.32 | 2024 | Cequr Simplicity |
| Medtronic, INC. | $95.09 | 2023-2024 | Propel, Sinuva |
| Intersect Ent, INC. | $87.17 | 2019-2022 | |
| Livanova USA, INC. | $58.15 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $52.45 | 2024-2025 | Dupixent |
| Merck Sharp & Dohme LLC | $45.16 | 2021-2023 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $37.66 | 2025 | Inspire |
| Checkpoint Surgical, INC | $35.49 | 2021-2022 | |
| Organogenesis INC. | $28.49 | 2024 | |
| Alk-Abello, INC | $26.91 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $25.77 | 2025 | Tezspire |
| Ethicon US, LLC | $24.79 | 2019 | |
| Boston Scientific Corporation | $22.31 | 2022 | |
| Itamar Medical INC | $21.84 | 2023 | Watchpatone |
| Travere Therapeutics, INC. | $15.64 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.66 | 2019 | |
| Medtronic USA, INC. | $14.65 | 2020 | |
| Bolder Surgical, LLC | $13.91 | 2022 | |
| Fortovia Therapeutics, INC. | $13.35 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $12.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Tarin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.